July 1, 2014 Ohio State Innovation Foundation Attn: Timothy R. Wright, President 1524 North High Street Columbus, Ohio 43201 Re: License Agreements/Upfront Fees/Equity Dear Mr. Wright: Reference is made to (1) the Patent & Technology License...

Exhibit 10.27

July 1, 0000

Xxxx Xxxxx Innovation Foundation
Attn: Xxxxxxx X. Xxxxxx, President
0000 Xxxxx Xxxx Xxxxxx
Xxxxxxxx, Xxxx 00000

Re: License Agreements/Upfront Fees/Equity

Dear Xx. Xxxxxx:

Reference is made to (1) the Patent & Technology License Agreement, Agt. No. A2014-0165, entered into as of September 6, 2013, by and between Microlin Bio, Inc. (“Microlin”) and Ohio State Innovation Foundation (“XXXX”), as amended, (2) the Patent & Technology License Agreement, Agt. No. A2013-2080, entered into as of September 6, 2013, by and between Microlin and XXXX, as amended, (3) the Patent & Technology License Agreement, Agt. No. A2013-2069, entered into as of September 6, 2013, by and between Microlin and XXXX, as amended, (4) the Patent & Technology License Agreement, Agt. No. A2014-0164, entered into as of September 6, 2013, by and between Microlin and XXXX, as amended, (5) the Patent & Technology License Agreement, Agt. No. A2014-0294, entered into as of September 6, 2013, by and between Microlin and XXXX, as amended (collectively, the “Agreements”), and (6) the letter agreement, entered into as of May 22, 2014, by and between Microlin and XXXX (the “May Letter Agreement”).

This letter serves to confirm our agreement regarding Microlin’s obligations with respect to the fees and expenses due to XXXX for the patents licensed from XXXX under the Agreements. The Agreements provide that Microlin is to pay XXXX an upfront fee (the “Upfront Fee”) for the licensed patents and to repay XXXX for past patent expenses (the “Patent Expenses”). The Agreements further provide that the Patent Expenses become immediately due and payable to XXXX in the event that $10,000,000 of external funding is obtained by Microlin.

Microlin and XXXX agree that the entire unpaid balance of the Upfront Fee, which totals $500,000 in the aggregate, will be paid in full by Microlin on or before August 1, 2014, $300,000 of which will be paid by Microlin to XXXX via wire transfer no later than three (3) calendar days after the day on which Microlin delivers its registered securities to its underwriter(s) and receives payment for such securities (the “Closing Date”), and $200,000 of which shall, on the date Microlin’s registration statement on Form S-1 filed in connection with the initial public offering of its common shares (the “Initial Public Offering”) is deemed effective (the “Effective Date”), automatically convert in whole, without any further action by XXXX, into shares of common stock of Microlin (the “Common Stock”), with the same rights, obligations, preferences and privileges as are received by the other holders of Common Stock (the “Upfront Fee Conversion”). Upon the Upfront Fee Conversion, XXXX shall receive (1) the number of shares of Common Stock equal to the quotient of (x) $200,000 divided by (y) the initial public offering price of the Common Stock and (2) warrants in the same proportion as issued to other investors in the initial public offering. Microlin shall, promptly after the Upfront Fee Conversion, issue and deliver to XXXX a certificate or certificates evidencing the shares of Common Stock to which XXXX shall be entitled. XXXX shall be treated for all purposes as the record holder of such shares of Common Stock as of the date of the Upfront Fee Conversion. In the event that the Effective Date does not occur or occurs after August 1, 2014, the parties will agree to a commercially reasonable alternative payment schedule for the Upfront Fee. Microlin and XXXX acknowledge that the foregoing agreement with respect to the Upfront Fee supersedes the May Letter Agreement.

In the event Microlin raises in excess of $10,000,000 in its Initial Public Offering on or before August 1, 2014, the entire unpaid balance of the Patent Expenses, which totals $2,446,000 in the aggregate, shall, on the Effective Date, automatically convert in whole, without any further action by XXXX, into shares of Common Stock with the same rights, obligations, preferences and privileges as are received by the other holders of Common Stock (the “Patent Expense Conversion”). Upon the Patent Expense Conversion, XXXX shall receive (1) the number of shares of Common Stock equal to the quotient of (x) $2,446,000 divided by (y) the initial public offering price of the Common Stock and (2) warrants in the same proportion as issued to other investors in the initial public offering. Microlin shall, promptly after the Patent Expense Conversion, issue and deliver to XXXX a certificate or certificates evidencing the shares of Common Stock to which XXXX shall be entitled. XXXX shall be treated for all purposes as the record holder of such shares of Common Stock as of the date of the Patent Expense Conversion. In the event that the Effective Date does not occur or occurs after August 1, 2014, the parties will agree to a commercially reasonable alternative payment schedule for the Patent Expenses.

Sincerely,

/s/ Xxxxxx Xxxxxxxxx

Xxxxxx Xxxxxxxxx

Executive Chairman

[Acknowledgement page follows]

ACKNOWLEDGED AND AGREED TO BY:

OHIO STATE INNOVATION FOUNDATION

By: /s/ Xxxxxxx X. Xxxxxx

Name: Xxxxxxx X. Xxxxxx

Title: President